other material
confidence high
sentiment positive
materiality 0.60
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV): restructuring charge — Clover Health exits ACO REACH, expects $8M-$10M charges; sees faster path to profitability
CLOVER HEALTH INVESTMENTS, CORP. /DE
- Board decided to exit CMS ACO REACH Program; notice delivered Dec 1, 2023, effective end of 2023 performance year.
- Total charges estimated at $8M to $10M, including $6M non-cash impairment in Q4 2023.
- CEO says no clear line to profitability in ACO REACH; Medicare Advantage business making swifter strides.
- Exit has no impact on ACO REACH beneficiaries; Clover will fulfill 2023 obligations.
- Company expects Adjusted EBITDA profitability for full-year 2024.